Accelerating Riboswitch Engineering for the Development of Human Performance Biosensors - A Preview of Strateos’ Presentation at SynBioBeta 2021

SynBioBeta 2021 – the Global Synthetic Biology Conference – will take place between January 25th - 27th 2022 in Oakland, California. Strateos’ own Daniel Rines, Ph.D., Senior Director, R&D Strategy, will be delivering a presentation highlighting how Strateos' smart lab platform accelerated riboswitch engineering to develop novel biosensors.

SynBioBeta is one of synthetic biology’s premier events, bringing together a diverse community of thought leaders, technology innovators, engineers, scientists, and policy makers to explore the exciting new advancements that are shaping the future of science. Strateos is pleased to take part alongside other industry and academic peers like Ginkgo Bioworks, Synthego, Stanford University, Harvard University and more.

The goal of synthetic biology programs is to engineer biological systems to have altered or new functions that can have far-reaching and transformative potential in a number of different sectors—from improving human health, to producing renewable fuel sources. However, traditional bioengineering approaches require manual iterative processes and often result in non-standardized data sets that extend development times hindering forward progress in the field.

AUTOMATION CAN OVERCOME BOTTLENECKS IN SYNTHETIC BIOLOGY PIPELINES

Daniels’ talk entitled Accelerating Riboswitch Engineering for the Development of Human Performance Biosensors outlines a recent client collaboration with the Air Force Research Laboratory (AFRL) where Strateos’ automated cloud lab was leveraged to accelerate rational design of novel riboswitches as biosensors that recognize the biomarker serotonin. Owing to their modular organization, riboswitches are ideal for engineering de novo sensing elements for use in synthetic biology.

Learn how Strateos’ automated synthetic biology modules supported rapid, iterative screening of RNA sequences in modular pbuE expression system and E. coli extract-based cell-free protein expression assays. Reducing the Design-Build-Test-Learn (DBTL) cycle times and generation of model-quality data through automation enables faster, more agile movement through synthetic biology pipelines.

Join in on the conversation at Synbiobeta 2021. We look forward to connecting with you soon!

For general conference information and/or to register:  https://2021.synbiobeta.com/

To learn more about our synthetic biology services: https://strateos.com/synthetic-biology/